Economic Observer Network: IDEXX Laboratories (IDXX.OQ) will undergo a CEO change in 2026, and recent financial data and stock performance have been announced.
Executive Changes
IDEXX Laboratories announced on January 13, 2026, that Dr. Michael (Mike) Erickson will be promoted to President and CEO on May 12, 2026. At that time, the current President and CEO, Jonathan (Jay) Mazelsky, will transition to Chairman of the Board. Mazelsky has announced plans to retire after the company’s annual shareholder meeting in May 2027 and will ensure a smooth leadership transition during this period.
Recent Stock Performance
On January 7, 2026, IDEXX’s stock experienced a significant movement, rising sharply by 2.62% to $700.08. Previously, on December 17, 2025, the stock also increased by 1.13%.
Financial and Operating Performance
Recent financial reports show the company’s revenue at $1.105 billion, net profit at $275 million, and earnings per share at $3.43.
The above information is compiled from public sources and does not constitute investment advice.
View Original
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
Adesys 2026 CEO Succession Plan and Recent Market Performance
Economic Observer Network: IDEXX Laboratories (IDXX.OQ) will undergo a CEO change in 2026, and recent financial data and stock performance have been announced.
Executive Changes
IDEXX Laboratories announced on January 13, 2026, that Dr. Michael (Mike) Erickson will be promoted to President and CEO on May 12, 2026. At that time, the current President and CEO, Jonathan (Jay) Mazelsky, will transition to Chairman of the Board. Mazelsky has announced plans to retire after the company’s annual shareholder meeting in May 2027 and will ensure a smooth leadership transition during this period.
Recent Stock Performance
On January 7, 2026, IDEXX’s stock experienced a significant movement, rising sharply by 2.62% to $700.08. Previously, on December 17, 2025, the stock also increased by 1.13%.
Financial and Operating Performance
Recent financial reports show the company’s revenue at $1.105 billion, net profit at $275 million, and earnings per share at $3.43.
The above information is compiled from public sources and does not constitute investment advice.